scutellarin has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Z; Lei, J; Xie, Z; Yu, J | 1 |
1 other study(ies) available for scutellarin and Ovarian Neoplasms
| Article | Year |
|---|---|
Scutellarin synergistically enhances cisplatin effect against ovarian cancer cells through enhancing the ability of cisplatin binding to DNA.
Topics: Antineoplastic Agents; Apigenin; Cell Line, Tumor; Cell Survival; Cisplatin; DNA; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Glucuronates; Humans; Ovarian Neoplasms | 2019 |